Annette Kuenkele Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Preclinical assessment of CD171-directed CAR T cell adoptive therapy for childhood neuroblastoma: CE7 epitope target safety and product manufacturing feasibility — Parallel 12 Immunotherapy and Early Phase Trials